Virtual Clinical Trials Market Size, Share & Trends Report

Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease), By Phase, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68039-239-7
Number of Pages: 133
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Virtual Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)
- Interventional
- Observational
- Expanded Access
Virtual Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)
- CNS
- Autoimmune/Inflammation
- Cardiovascular Disease
- Metabolic/Endocrinology
- Infectious Disease
- Oncology
- Genitourinary
- Ophthalmology
- Others
Virtual Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Virtual Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Virtual Clinical Trials Market, By Study Design
    - Interventional
    - Observational
    - Expanded Access
  - North America Virtual Clinical Trials Market, By Indication
    - CNS
    - Autoimmune/Inflammation
    - Cardiovascular Disease
    - Metabolic/Endocrinology
    - Infectious Disease
    - Oncology
    - Genitourinary
    - Ophthalmology
    - Others
  - North America Virtual Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - U.S.
    - U.S. Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - U.S. Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - U.S. Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Canada
    - Canada Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Canada Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Canada Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
- Europe
  - Europe Virtual Clinical Trials Market, By Study Design
    - Interventional
    - Observational
    - Expanded Access
  - Europe Virtual Clinical Trials Market, By Indication
    - CNS
    - Autoimmune/Inflammation
    - Cardiovascular Disease
    - Metabolic/Endocrinology
    - Infectious Disease
    - Oncology
    - Genitourinary
    - Ophthalmology
    - Others
  - Europe Virtual Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - UK
    - UK Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - UK Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - UK Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Germany
    - Germany Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Germany Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Germany Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - France
    - France Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - France Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - France Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Italy
    - Italy Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Italy Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Italy Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Spain
    - Spain Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Spain Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Spain Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Denmark
    - Denmark Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Denmark Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Denmark Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Sweden
    - Sweden Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Sweden Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Sweden Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Norway
    - Norway Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Norway Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Norway Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
- Asia Pacific
  - Asia Pacific Virtual Clinical Trials Market, By Study Design
    - Interventional
    - Observational
    - Expanded Access
  - Asia Pacific Virtual Clinical Trials Market, By Indication
    - CNS
    - Autoimmune/Inflammation
    - Cardiovascular Disease
    - Metabolic/Endocrinology
    - Infectious Disease
    - Oncology
    - Genitourinary
    - Ophthalmology
    - Others
  - Asia Pacific Virtual Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Japan
    - Japan Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Japan Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Japan Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - China
    - China Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - China Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - China Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - India
    - India Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - India Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - India Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Australia
    - Australia Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Australia Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Australia Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Thailand
    - Thailand Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Thailand Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Thailand Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - South Korea
    - South Korea Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - South Korea Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - South Korea Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
- Latin America
  - Latin America Virtual Clinical Trials Market, By Study Design
    - Interventional
    - Observational
    - Expanded Access
  - Latin America Virtual Clinical Trials Market, By Indication
    - CNS
    - Autoimmune/Inflammation
    - Cardiovascular Disease
    - Metabolic/Endocrinology
    - Infectious Disease
    - Oncology
    - Genitourinary
    - Ophthalmology
    - Others
  - Latin America Virtual Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Brazil
    - Brazil Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Brazil Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Brazil Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Mexico
    - Mexico Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Mexico Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Mexico Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Argentina
    - Argentina Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Argentina Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Argentina Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
- MEA
  - MEA Virtual Clinical Trials Market, By Study Design
    - Interventional
    - Observational
    - Expanded Access
  - MEA Virtual Clinical Trials Market, By Indication
    - CNS
    - Autoimmune/Inflammation
    - Cardiovascular Disease
    - Metabolic/Endocrinology
    - Infectious Disease
    - Oncology
    - Genitourinary
    - Ophthalmology
    - Others
  - MEA Virtual Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - South Africa
    - South Africa Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - South Africa Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - South Africa Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Saudi Arabia
    - Saudi Arabia Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Saudi Arabia Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Saudi Arabia Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - UAE
    - UAE Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - UAE Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - UAE Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
  - Kuwait
    - Kuwait Virtual Clinical Trials Market, By Study Design
      - Interventional
      - Observational
      - Expanded Access
    - Kuwait Virtual Clinical Trials Market, By Indication
      - CNS
      - Autoimmune/Inflammation
      - Cardiovascular Disease
      - Metabolic/Endocrinology
      - Infectious Disease
      - Oncology
      - Genitourinary
      - Ophthalmology
      - Others
    - Kuwait Virtual Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV

Virtual Clinical Trials Market Dynamics

Driver: The Growing Role of Technology in Healthcare

It has been observed that the current way of conducting a traditional clinical trial is coming to an end as the rising cost of running trials together with the commercial risk of failure is unsustainable. As progress is being made toward a more digitalized scenario, clinical studies are driven by the increasing adoption of advanced technologies that rapidly accelerate the digital transformation of their processes. As clinical trials are not optional, shifting to advanced technology & digital innovation is a solution to combat the problems associated with traditional clinical trials. Digital clinical trials, which were just a concept earlier, are now on track to become a reality. Digital technology is transforming the entire process of drug development. The advent of mobile & wearables, artificial intelligence (AI), cloud technology, and associated platforms now enable the collection of frequent, precise, and multidimensional data during the length of trials.

Driver: Benefits of Virtual Trials

As compared to traditional study models, the strength of the concept of virtual trial is the ability to make it easier to include patients from diverse regions, rural areas, and different socio-economic backgrounds in clinical trials. The traditional system requires many on-site procedures that consume a patient’s time. The average patient cannot take one day off every week to take part in clinical trials. Various protocols have two to five times the number of visits or procedures a patient would receive for the management of disease in the usual course of care. Thus, this increases patient burden, making it difficult to recruit & retain participants for clinical trials. Patients have to travel to sites that may be far from their homes and take an average of two to three hours to reach. Hence, only about 3% to 5% of eligible people get to enroll in clinical trials and there is a 30% dropout rate for those who do enroll in all clinical trials.

Restraint: Recruitment Obstacles

The success of clinical trials depends on the level of engagement of its clinical staff, oncologists, and patients from the very first phase. Unfortunately, several barriers are present within these groups for both psychological and logistical reasons. Consequently, less than 5% of adult patients diagnosed with cancer register in clinical trials. This is mainly due to various reasons including availability of trial, oncologist’s willingness to propose enrollment, site access, commitment of clinical staff, and patient concerns. Cancer researchers face considerable challenges in patient recruitment. As of June 2019, approximately 14,000 oncology trials were actively recruiting with a participation rate of 3% to 8% of possible candidates, with an even more limited number in minority and geriatric populations. Low rate of enrollment poses risks to the success of specific clinical trials and may hamper treatment advances & corresponding benefits to outcomes.

What Does This Report Include?

This section will provide insights into the contents included in this virtual clinical trials market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Virtual clinical trials market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Virtual clinical trials market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.